{"id":"week-60","safety":{"commonSideEffects":[{"rate":"1-5%","effect":"Pneumonitis"},{"rate":"1-5%","effect":"Hypothyroidism"},{"rate":"1-5%","effect":"Diarrhea"},{"rate":"1-5%","effect":"Fatigue"},{"rate":"1-5%","effect":"Nausea"},{"rate":"1-5%","effect":"Rash"},{"rate":"1-5%","effect":"Pruritus"},{"rate":"1-5%","effect":"Arthralgia"},{"rate":"1-5%","effect":"Myalgia"},{"rate":"1-5%","effect":"Headache"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By binding to PD-1, the drug prevents cancer cells from evading the immune system, allowing the body's immune cells to attack and destroy the cancer cells. This leads to an anti-tumor response and potentially prolonged survival in patients with certain types of cancer.","oneSentence":"This drug targets the PD-1 receptor to inhibit cancer cell growth.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-28T01:41:05.802Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Non-small cell lung cancer, PD-L1 positive"},{"name":"Melanoma"}]},"trialDetails":[{"nctId":"NCT07485959","phase":"NA","title":"The Effect of NP-2006 on Sleep Quality and Health","status":"COMPLETED","sponsor":"Hanpoong Nature Pharm Co., Ltd.","startDate":"2023-05-12","conditions":"Sleep Disorder (Disorder)","enrollment":48},{"nctId":"NCT07495540","phase":"NA","title":"Comparison of the Effects of Free Weight and Machine-Based Exercises on Muscular Parameters","status":"NOT_YET_RECRUITING","sponsor":"Biruni University","startDate":"2026-03-23","conditions":"Resistance Exercise, Neuromuscular Adaptations, Muscle","enrollment":26},{"nctId":"NCT04759586","phase":"PHASE3","title":"Nivolumab in Combination With Chemo-Immunotherapy for the Treatment of Newly Diagnosed Primary Mediastinal B-Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-10-05","conditions":"Primary Mediastinal Large B-Cell Lymphoma","enrollment":244},{"nctId":"NCT02306161","phase":"PHASE3","title":"Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing Sarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2014-12-12","conditions":"Metastatic Ewing Sarcoma, Metastatic Malignant Neoplasm in the Bone, Metastatic Malignant Neoplasm in the Bone Marrow","enrollment":312},{"nctId":"NCT07496151","phase":"NA","title":"The Effectiveness of Neurodevelopmental Treatment (Bobath) and Functional Physiotherapy in Children With Cerebral Palsy.","status":"NOT_YET_RECRUITING","sponsor":"University of Thessaly","startDate":"2026-03-15","conditions":"Cerebral Palsy (CP)","enrollment":40},{"nctId":"NCT07454330","phase":"NA","title":"Study of a Support Program for Quality of Life in Chinese Cancer Patients and Survivors","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2026-02-27","conditions":"Cancer, Survivorship","enrollment":64},{"nctId":"NCT06985056","phase":"NA","title":"Reducing Symptom Burden Through Physical Exercise in Melanoma Patients","status":"RECRUITING","sponsor":"Universität Duisburg-Essen","startDate":"2025-08-18","conditions":"Malignant Melanoma","enrollment":104},{"nctId":"NCT04317105","phase":"PHASE1, PHASE2","title":"Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-07-17","conditions":"Advanced Malignant Solid Neoplasm, Metastatic Malignant Solid Neoplasm, Unresectable Malignant Solid Neoplasm","enrollment":54},{"nctId":"NCT03739411","phase":"PHASE1","title":"Hyperpolarized Imaging in Diagnosing Participants With Glioma","status":"RECRUITING","sponsor":"Susan Chang","startDate":"2015-12-09","conditions":"Glioma","enrollment":140},{"nctId":"NCT04512456","phase":"NA","title":"Cardiovascular Responses to Exercise in People Living With HIV/AIDS: Effects of Exercise Training","status":"RECRUITING","sponsor":"Instituto Nacional de Cardiologia de Laranjeiras","startDate":"2024-08-01","conditions":"HIV Infections","enrollment":63},{"nctId":"NCT06966700","phase":"PHASE3","title":"A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)","status":"RECRUITING","sponsor":"Merck Sharp & Dohme LLC","startDate":"2025-06-30","conditions":"Breast Neoplasms, Triple Negative Breast Neoplasms, HR Low-Positive/HER2-Negative Breast Neoplasms","enrollment":2400},{"nctId":"NCT04052555","phase":"PHASE1","title":"Testing the Addition of an Anti-cancer Drug, Berzosertib, to the Usual Treatment (Radiation Therapy) for Chemotherapy-Resistant Triple-Negative and Estrogen and/or Progesterone Receptor Positive, HER2 Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-09-24","conditions":"Bilateral Breast Carcinoma, HER2-Negative Breast Carcinoma, Localized Breast Carcinoma","enrollment":42},{"nctId":"NCT04164082","phase":"PHASE2","title":"Testing the Addition of an Anti-cancer Drug, Pembrolizumab, to the Usual Intravesical Chemotherapy Treatment (Gemcitabine) for the Treatment of BCG-Unresponsive Non-muscle Invasive Bladder Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-03-18","conditions":"Bladder Flat Urothelial Carcinoma In Situ, Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8","enrollment":161},{"nctId":"NCT04310020","phase":"PHASE2","title":"Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-01-13","conditions":"Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage III Lung Cancer AJCC v8","enrollment":47},{"nctId":"NCT03811015","phase":"PHASE3","title":"Testing Immunotherapy Versus Observation in Patients With HPV Throat Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-16","conditions":"Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":636},{"nctId":"NCT07497425","phase":"NA","title":"Neuroimmune Responses to Exercise in Chronic Back Pain","status":"RECRUITING","sponsor":"McGill University","startDate":"2025-06-01","conditions":"Chronic Low Back Pain (CLBP)","enrollment":216},{"nctId":"NCT07055581","phase":"PHASE2","title":"Durvalumab as Consolidation for Patients LS-SCLC","status":"RECRUITING","sponsor":"Qian Chu","startDate":"2026-02-24","conditions":"Small Cell Lung Cancer Limited Stage","enrollment":100},{"nctId":"NCT00092222","phase":"PHASE2","title":"Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease Activity","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2004-10-28","conditions":"Lymphoproliferative Disorder, HHV-8, Malignancy","enrollment":75},{"nctId":"NCT02834013","phase":"PHASE2","title":"Nivolumab and Ipilimumab in Treating Patients With Rare Tumors","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-01-30","conditions":"Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma","enrollment":818},{"nctId":"NCT02567435","phase":"PHASE3","title":"Combination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk Rhabdomyosarcoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-06-01","conditions":"Alveolar Rhabdomyosarcoma, Botryoid-Type Embryonal Rhabdomyosarcoma, Embryonal Rhabdomyosarcoma","enrollment":325},{"nctId":"NCT07498933","phase":"","title":"FAP-targeted PET/NIR in Lung Malignant Tumors","status":"RECRUITING","sponsor":"Peking University People's Hospital","startDate":"2025-06-03","conditions":"Non-Small Cell Lung Cancer, PET/CT, Neoadjuvant Therapy","enrollment":200},{"nctId":"NCT07497529","phase":"NA","title":"WhatsApp Radio Taiso Exercise Program for Adults Aged 60+","status":"RECRUITING","sponsor":"Ondokuz Mayıs University","startDate":"2026-03-10","conditions":"Older Adults (60 - 85 Years Old)","enrollment":30},{"nctId":"NCT07494149","phase":"NA","title":"Group-Based Exercise Intervention to Prevent Cognitive and Motor Decline","status":"RECRUITING","sponsor":"University of Bergamo","startDate":"2026-02-01","conditions":"Healthy, Older Adults","enrollment":158},{"nctId":"NCT06029270","phase":"PHASE2","title":"Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Metastatic Nasopharyngeal Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2024-07-15","conditions":"Metastatic Nasopharyngeal Carcinoma, Recurrent Nasopharyngeal Carcinoma, Stage IV Nasopharyngeal Carcinoma AJCC v8","enrollment":156},{"nctId":"NCT07498257","phase":"NA","title":"Adaptation and RCT of Written Exposure Therapy for Adolescents","status":"NOT_YET_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-03-05","conditions":"Posttraumatic Stress Disorder (PTSD)","enrollment":48},{"nctId":"NCT07494357","phase":"NA","title":"Effects of Dual Task-Oriented Circuit Training on Walking Recovery in Sub-acute Stroke","status":"NOT_YET_RECRUITING","sponsor":"Universitas Padjadjaran","startDate":"2026-04-01","conditions":"Stroke, Cerebrovascular","enrollment":36},{"nctId":"NCT04503694","phase":"PHASE2","title":"Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Jules Bordet Institute","startDate":"2021-03-25","conditions":"Rectal Cancer Stage II, Rectal Cancer Stage III","enrollment":72},{"nctId":"NCT06273644","phase":"NA","title":"Clinical Research on Acute Intermittent Porphyria and the Use of Carbohydrate-Rich Diet as a Treatment","status":"RECRUITING","sponsor":"Nordlandssykehuset HF","startDate":"2024-01-27","conditions":"Porphyria, Acute Intermittent","enrollment":50},{"nctId":"NCT06807164","phase":"PHASE2","title":"Serratus Plane Block (SPB) Versus Capsaïcine Versus Botox-A for Chronic Neuropathic Pain in Post-mastectomy Syndrome","status":"RECRUITING","sponsor":"Centre Oscar Lambret","startDate":"2026-03-31","conditions":"Post-Mastectomy Neuropathic Pain Syndrome","enrollment":123},{"nctId":"NCT03954210","phase":"NA","title":"SIESTA: Sleep Intervention to Enhance Cognitive Status and Reduce Beta Amyloid","status":"COMPLETED","sponsor":"University of Kansas Medical Center","startDate":"2019-08-27","conditions":"Insomnia","enrollment":200},{"nctId":"NCT05198830","phase":"PHASE2","title":"Testing the Addition of an Anti-Cancer Drug, TRC102, to the Usual Chemotherapy Treatment (Pemetrexed, Cisplatin or Carboplatin) During Radiation Therapy for Stage III Non-Squamous Non-Small Cell Lung Cancer","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-12-15","conditions":"Lung Adenocarcinoma, Lung Large Cell Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma","enrollment":42},{"nctId":"NCT03321643","phase":"PHASE1","title":"Testing the Addition of an Immunotherapy Agent, Atezolizumab, When Given With the Usual Chemo-Immunotherapy Drug Combination (Rituximab Plus Gemcitabine and Oxaliplatin) for Relapsed/Refractory (That Has Come Back or Not Responded to Treatment) Transformed Diffuse Large B-Cell Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-09-18","conditions":"Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Transformed Non-Hodgkin Lymphoma, Refractory Diffuse Large B-Cell Lymphoma","enrollment":24},{"nctId":"NCT07495579","phase":"PHASE2","title":"Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)","status":"NOT_YET_RECRUITING","sponsor":"Asan Medical Center","startDate":"2026-04","conditions":"Hepatocellular Carcinoma (HCC)","enrollment":146},{"nctId":"NCT04351256","phase":"PHASE2","title":"Thoracic Radiotherapy Plus Durvalumab in Elderly and/or Frail NSCLC Stage III Patients Unfit for Chemotherapy","status":"COMPLETED","sponsor":"Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest","startDate":"2020-05-20","conditions":"NSCLC, Stage III","enrollment":51},{"nctId":"NCT03297606","phase":"PHASE2","title":"Canadian Profiling and Targeted Agent Utilization Trial (CAPTUR)","status":"RECRUITING","sponsor":"Canadian Cancer Trials Group","startDate":"2018-03-23","conditions":"Lymphoma, Non-Hodgkin, Multiple Myeloma, Advanced Solid Tumors","enrollment":720},{"nctId":"NCT06923800","phase":"NA","title":"Exercise Interventions and Dietary Advice in Fibromyalgia and IBS","status":"RECRUITING","sponsor":"Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis","startDate":"2025-04-14","conditions":"Fibromyalgia, Irritable Bowel Syndrome","enrollment":30},{"nctId":"NCT02997228","phase":"PHASE3","title":"Testing the Addition of Atezolizumab to Combination Chemotherapy or Atezolizumab Alone for Metastatic Colon or Rectal Cancer, the COMMIT Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2018-01-19","conditions":"Metastatic Colorectal Adenocarcinoma, Stage IV Colorectal Cancer AJCC v7","enrollment":120},{"nctId":"NCT03328026","phase":"PHASE1, PHASE2","title":"Combination Study of SV-BR-1-GM With Retifanlimab","status":"COMPLETED","sponsor":"BriaCell Therapeutics Corporation","startDate":"2018-03-16","conditions":"Breast Cancer, Breast Neoplasm, Metastatic Breast Cancer","enrollment":36},{"nctId":"NCT07495085","phase":"NA","title":"Manual Therapy in Improving Quality of Life in Women With Dyspareunia","status":"COMPLETED","sponsor":"University of Trás-os-Montes and Alto Douro","startDate":"2025-02-01","conditions":"Female, Dyspareunia","enrollment":50},{"nctId":"NCT04533750","phase":"PHASE1","title":"Testing the Addition of M3814 (Peposertib) to Radiation Therapy for Patients With Advanced Head and Neck Cancer Who Cannot Take Cisplatin","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-12-20","conditions":"Advanced Head and Neck Squamous Cell Carcinoma, Advanced Hypopharyngeal Squamous Cell Carcinoma, Advanced Laryngeal Squamous Cell Carcinoma","enrollment":21},{"nctId":"NCT07045038","phase":"NA","title":"Blood Flow Restricted Resistance Exercises Versus Low Level Laser on Cardiac Functions in Patients With Chronic Heart Failure","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cairo University","startDate":"2025-01-20","conditions":"Heart Failure NYHA Class II","enrollment":60},{"nctId":"NCT03914612","phase":"PHASE3","title":"Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-08-22","conditions":"Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma, Endometrial Endometrioid Adenocarcinoma","enrollment":813},{"nctId":"NCT06875102","phase":"NA","title":"Fatigue in Sjögren's Syndrome: 3 Therapeutic Strategies","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2026-03-24","conditions":"Sjogren Syndrome","enrollment":174},{"nctId":"NCT03952585","phase":"PHASE2, PHASE3","title":"De-intensified Radiation Therapy With Chemotherapy (Cisplatin) or Immunotherapy (Nivolumab) in Treating Patients With Early-Stage, HPV-Positive, Non-Smoking Associated Oropharyngeal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-10-09","conditions":"Basaloid Squamous Cell Carcinoma, Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8","enrollment":384},{"nctId":"NCT04034927","phase":"PHASE2","title":"Testing the Addition of an Immunotherapy Drug, Tremelimumab, to the PARP Inhibition Drug, Olaparib, for Recurrent Ovarian, Fallopian Tube or Peritoneal Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-12-04","conditions":"Fallopian Tube Endometrioid Tumor, Fallopian Tube High Grade Serous Adenocarcinoma, Malignant Ovarian Endometrioid Tumor","enrollment":61},{"nctId":"NCT06959771","phase":"PHASE1, PHASE2","title":"Base Editing Hematopoietic Stem Cell and T Cell Gene Therapy for CD40L-HyperIgM Syndrome: Single Patient Study","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2025-07-16","conditions":"CD40L-HyperIgM Syndrome","enrollment":1},{"nctId":"NCT07498530","phase":"NA","title":"Virtual Assistant for Exercise Adherence in Older ADULTS","status":"RECRUITING","sponsor":"University of Valencia","startDate":"2026-02-01","conditions":"Older Adult, Exercise, Adherence","enrollment":70},{"nctId":"NCT05256225","phase":"PHASE3","title":"Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2 Positive Endometrial Serous Carcinoma or Carcinosarcoma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-11-16","conditions":"Endometrial Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Dedifferentiated Carcinoma","enrollment":360},{"nctId":"NCT02275533","phase":"PHASE2","title":"Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-07-02","conditions":"Acute Myeloid Leukemia","enrollment":82},{"nctId":"NCT07497334","phase":"NA","title":"A Novel Multi-Modal Approach to Promote Functional Outcomes in Cognitively Frail Older Adults","status":"RECRUITING","sponsor":"The Hong Kong Polytechnic University","startDate":"2025-01-05","conditions":"Frailty at Older Adults, Mild Cognitive Impairment","enrollment":45},{"nctId":"NCT07388524","phase":"PHASE3","title":"Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial","status":"NOT_YET_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2026-04-09","conditions":"Lung Non-Small Cell Carcinoma","enrollment":336},{"nctId":"NCT04092283","phase":"PHASE3","title":"Testing the Addition of an Antibody to Standard Chemoradiation Followed by the Antibody for One Year to Standard Chemoradiation Followed by One Year of the Antibody in Patients With Unresectable Stage III Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-04-29","conditions":"Recurrent Lung Non-Small Cell Carcinoma, Stage III Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8","enrollment":660},{"nctId":"NCT06033196","phase":"PHASE2","title":"Tocilizumab in Lung Transplantation","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2024-02-13","conditions":"Lung Transplant","enrollment":350},{"nctId":"NCT06496230","phase":"EARLY_PHASE1","title":"Open Trial of Technology-Enhanced Behavioral Intervention for Buprenorphine Retention in Pregnant and Postpartum People","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2024-08-06","conditions":"Opioid Use Disorder, Pregnancy Related","enrollment":15},{"nctId":"NCT06732401","phase":"PHASE3","title":"Testing the Addition of AZD6738 (Ceralasertib) to Immunotherapy to Increase Time Without Cancer for Patients With Non-Small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2025-08-07","conditions":"Lung Non-Small Cell Carcinoma, Stage II Lung Cancer AJCC v8, Stage IIIA Lung Cancer AJCC v8","enrollment":630},{"nctId":"NCT06652789","phase":"NA","title":"Efficacy of Sleep Hygiene Intervention in Elderly With Insomnia","status":"NOT_YET_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2027-02","conditions":"Eelderly With Sleep Disturbances","enrollment":100},{"nctId":"NCT06059872","phase":"NA","title":"Biomarkers of Reaction To HIIT Exercise","status":"RECRUITING","sponsor":"VA Office of Research and Development","startDate":"2024-01-01","conditions":"Stroke, Stroke Rehabilitation, Lower Extremity Weakness, Spastic","enrollment":55},{"nctId":"NCT05001880","phase":"PHASE2","title":"Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma","status":"RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-03-22","conditions":"Peritoneal Malignant Mesothelioma","enrollment":66},{"nctId":"NCT04297683","phase":"PHASE2, PHASE3","title":"HEALEY ALS Platform Trial - Master Protocol","status":"RECRUITING","sponsor":"Merit E. Cudkowicz, MD","startDate":"2020-06-14","conditions":"Amyotrophic Lateral Sclerosis","enrollment":1500},{"nctId":"NCT06136897","phase":"PHASE2","title":"Testing Trastuzumab and Pertuzumab in Patients With Higher Than Normal Copies of the HER2 Gene Found in Their Tumors (MATCH - Subprotocol J)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-03-23","conditions":"Malignant Solid Neoplasm","enrollment":35},{"nctId":"NCT02465060","phase":"PHASE2","title":"Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2015-08-17","conditions":"Advanced Lymphoma, Advanced Malignant Solid Neoplasm, Bladder Carcinoma","enrollment":6452},{"nctId":"NCT04729959","phase":"PHASE2","title":"Testing the Addition of the Immune Therapy Drugs, Tocilizumab and Atezolizumab, to Radiation Therapy for Recurrent Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2022-03-11","conditions":"Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma","enrollment":59},{"nctId":"NCT04214262","phase":"PHASE3","title":"Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-08-13","conditions":"Lung Non-Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8","enrollment":480},{"nctId":"NCT02453620","phase":"PHASE1","title":"Entinostat, Nivolumab, and Ipilimumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery or Locally Advanced or Metastatic HER2-Negative Breast Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2016-02-12","conditions":"Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Breast Adenocarcinoma","enrollment":57},{"nctId":"NCT02535702","phase":"NA","title":"Development Of Neuroimaging Methods To Assess The Neurobiology Of Addiction","status":"RECRUITING","sponsor":"National Institute on Alcohol Abuse and Alcoholism (NIAAA)","startDate":"2016-06-28","conditions":"Normal Physiology","enrollment":192},{"nctId":"NCT06310161","phase":"NA","title":"Light Therapy in End Stage Kidney Disease","status":"RECRUITING","sponsor":"University of Pennsylvania","startDate":"2026-02-01","conditions":"End Stage Renal Disease","enrollment":60},{"nctId":"NCT03871257","phase":"PHASE3","title":"A Study of the Drugs Selumetinib Versus Carboplatin/Vincristine in Patients With Neurofibromatosis and Low-Grade Glioma","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2020-01-15","conditions":"Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma","enrollment":165},{"nctId":"NCT06346028","phase":"PHASE4","title":"Implementation of Transcranial Magnetic Stimulation for Smoking Cessation","status":"RECRUITING","sponsor":"Centre for Addiction and Mental Health","startDate":"2024-03-30","conditions":"Smoking","enrollment":40},{"nctId":"NCT06579807","phase":"NA","title":"Cardiac Rehabilitation and Coronary Artery Disease","status":"RECRUITING","sponsor":"Instituto Nacional de Cardiologia de Laranjeiras","startDate":"2024-10-01","conditions":"Coronary Artery Disease, Atherosclerosis","enrollment":50},{"nctId":"NCT02888743","phase":"PHASE2","title":"Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2017-08-14","conditions":"Metastatic Colorectal Carcinoma, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Colorectal Cancer AJCC v7","enrollment":110},{"nctId":"NCT06732245","phase":"PHASE2","title":"Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese","status":"NOT_YET_RECRUITING","sponsor":"Biomed Industries, Inc.","startDate":"2026-08-15","conditions":"Obesity and Overweight","enrollment":224},{"nctId":"NCT03775265","phase":"PHASE3","title":"Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-06-03","conditions":"Bladder Urothelial Carcinoma, Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8","enrollment":475},{"nctId":"NCT03811002","phase":"PHASE3","title":"Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC)","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2019-07-26","conditions":"Limited Stage Lung Small Cell Carcinoma, Stage I Lung Cancer AJCC v8, Stage II Lung Cancer AJCC v8","enrollment":544},{"nctId":"NCT07344298","phase":"NA","title":"Less is Better? Effectiveness of a Short Local Vibration Protocol on Neuromuscular Function","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2026-03-23","conditions":"Healthy Volonteers","enrollment":72},{"nctId":"NCT07494916","phase":"NA","title":"Effects of Functional Task Training on Muscle Health and Function in Older Adults With Sarcopenia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universidad de Granada","startDate":"2026-02-02","conditions":"Sarcopenia, Aging, Physical Functional Performance","enrollment":30},{"nctId":"NCT06280183","phase":"NA","title":"Functional Inspiratory Muscle Training in Obese Individuals","status":"COMPLETED","sponsor":"Biruni University","startDate":"2024-02-28","conditions":"Obesity","enrollment":45},{"nctId":"NCT05771480","phase":"PHASE3","title":"Durvalumab With Chemotherapy as First Line Treatment in Patients With Advanced Biliary Tract Cancers (aBTCs)","status":"ACTIVE_NOT_RECRUITING","sponsor":"AstraZeneca","startDate":"2023-08-16","conditions":"Biliary Tract Cancer","enrollment":142},{"nctId":"NCT02905591","phase":"PHASE2","title":"A Phase 2 Study Adding Ascorbate to Chemotherapy and Radiation Therapy for NSCLC","status":"ACTIVE_NOT_RECRUITING","sponsor":"Joseph J. Cullen, MD, FACS","startDate":"2018-11-16","conditions":"Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer, Nonsmall Cell Lung Cancer","enrollment":43},{"nctId":"NCT07486856","phase":"NA","title":"Motor-Cognitive Integrated Intervention for Children With Developmental Coordination Disorder","status":"COMPLETED","sponsor":"Shanghai University of Sport","startDate":"2025-03-01","conditions":"Developmental Coordination Disorder","enrollment":20},{"nctId":"NCT02615184","phase":"PHASE2","title":"A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old","status":"ACTIVE_NOT_RECRUITING","sponsor":"Takeda","startDate":"2023-05-23","conditions":"Erosive Esophagitis","enrollment":76},{"nctId":"NCT07492459","phase":"NA","title":"Effects of Motivational Interviewing Training on Nursing Students' Counselling Skills, Self-Efficacy, and Reluctance","status":"NOT_YET_RECRUITING","sponsor":"Ankara University","startDate":"2026-05","conditions":"Professional Competence, Health Communication","enrollment":72},{"nctId":"NCT07456956","phase":"NA","title":"HIIT vs MCIT for Stroke-Related Sarcopenia in Ischemic Stroke","status":"RECRUITING","sponsor":"Fenerbahce University","startDate":"2026-03-02","conditions":"Stroke, Ischemic, Sarcopenia","enrollment":32},{"nctId":"NCT07493538","phase":"PHASE2","title":"MT2025-35 Allogeneic Hematopoietic Stem Cell Transplantation Using Reduced Intensity Conditioning Treosulfan and Fludarabine, With Post-Transplant Cytoxan (PTCy) for the Treatment of Hematological Diseases","status":"NOT_YET_RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2026-08","conditions":"AML, MDS, Acute Leukemia","enrollment":132},{"nctId":"NCT07410481","phase":"NA","title":"Trial of Acceptance and Mindfulness-based Exposure Therapy (AMBET) and Present Centered Therapy (PCT)","status":"RECRUITING","sponsor":"Columbia University","startDate":"2026-03-30","conditions":"PTSD - Post Traumatic Stress Disorder, Cardiac Arrest (CA)","enrollment":90},{"nctId":"NCT06925724","phase":"PHASE2","title":"A Study of Ivonescimab in People With Endometrial and Cervical Cancers","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2025-04-04","conditions":"Endometrial Cancer, Cervical Cancer","enrollment":50},{"nctId":"NCT07492069","phase":"NA","title":"Life Skills-Based Intervention on Substance Use Intention in Adolescents in Social Care Institutions","status":"NOT_YET_RECRUITING","sponsor":"Universidad Autonoma de Baja California","startDate":"2026-08-30","conditions":"Institutionalization","enrollment":20},{"nctId":"NCT07165600","phase":"NA","title":"Yoga to Improve Disparities in Cancer Survivorship","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2025-09-24","conditions":"Survivorship, Cancer","enrollment":50},{"nctId":"NCT07482189","phase":"NA","title":"Effectiveness and Efficiency of an Upper Limb Active-Passive Exoskeleton Robot in Patients With Frozen Shoulder","status":"NOT_YET_RECRUITING","sponsor":"China Medical University Hospital","startDate":"2026-03-16","conditions":"Adhesive Capsulitis of the Shoulder, Frozen Shoulder","enrollment":40},{"nctId":"NCT07492615","phase":"PHASE2","title":"A Clinical Study of Sintilimab Combined With Chemothrapy Versus Chemotherapy as Adjuvant Therapy for Gastric/Gastroesophageal Junction Adenocarcinoma","status":"RECRUITING","sponsor":"Fudan University","startDate":"2026-01-29","conditions":"Gastric Cancer or Gastroesophageal Junction Adenocarcinoma","enrollment":276},{"nctId":"NCT06783452","phase":"NA","title":"Clinical Pilates in Hip Osteoarthritis: A Randomised Controlled Trial","status":"COMPLETED","sponsor":"Izmir Katip Celebi University","startDate":"2024-11-30","conditions":"Hip Osteoarthritis","enrollment":52},{"nctId":"NCT07493837","phase":"NA","title":"Land- and Water-based Inspiratory Muscle Training in Young Swimmers","status":"RECRUITING","sponsor":"Ondokuz Mayıs University","startDate":"2026-03-01","conditions":"Sport Performance, Inspiratory Muscle Training","enrollment":30},{"nctId":"NCT06676904","phase":"NA","title":"Neonatal Platelet Transfusion Threshold Trial","status":"RECRUITING","sponsor":"NICHD Neonatal Research Network","startDate":"2025-06-13","conditions":"Thrombocytopenia, Neonatal, Platelet Transfusion","enrollment":2433},{"nctId":"NCT07368907","phase":"NA","title":"Walk On! National Council on Aging Innovation Lab","status":"NOT_YET_RECRUITING","sponsor":"Wake Forest University Health Sciences","startDate":"2026-04","conditions":"Falls Prevention","enrollment":192},{"nctId":"NCT07488286","phase":"NA","title":"Playful Physical Activity Program and Executive Function in Preschool Children","status":"COMPLETED","sponsor":"Monira Aldhahi","startDate":"2025-01-10","conditions":"Executive Function, School Readiness","enrollment":48},{"nctId":"NCT07491536","phase":"NA","title":"Ozone Therapy With Biomimetic Oral Care for Cancer-Related Oral Mucositis","status":"RECRUITING","sponsor":"University of Pavia","startDate":"2026-03-01","conditions":"Oral Mucositis, Chemotherapy-induced Oral Mucositis, Head and Neck Neoplasms","enrollment":50},{"nctId":"NCT06538623","phase":"PHASE2","title":"Oxaliplatin Combined With Irinotecan Liposome Injection II Through Hepatic Artery Infusion (HAIC) Followed by 5-FU/LV (HAIC) or Tegorgor Oral Combination Therapy for Hepatic Metastasis of Pancreatic Cancer","status":"COMPLETED","sponsor":"Ruijin Hospital","startDate":"2024-08-23","conditions":"Pancreatic Neoplasms, Neoplasm Metastasis, Hepatic Metastasis of Pancreatic Cancer","enrollment":40},{"nctId":"NCT07481253","phase":"NA","title":"PSYCHOPATHY.COMP Program Among Male Prison Inmates With Psychopathy","status":"NOT_YET_RECRUITING","sponsor":"University of Coimbra","startDate":"2026-04-01","conditions":"Antisocial Personality Disorder (ASPD)","enrollment":200},{"nctId":"NCT04216316","phase":"PHASE1, PHASE2","title":"Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Cancer Institute (NCI)","startDate":"2021-04-14","conditions":"Lung Non-Small Cell Squamous Carcinoma, Stage IV Lung Cancer AJCC v8","enrollment":12},{"nctId":"NCT07447934","phase":"NA","title":"Trial to Test the Effectiveness of Vibrotactile Stimulation for Lower Limb Spasticity","status":"NOT_YET_RECRUITING","sponsor":"Weill Medical College of Cornell University","startDate":"2026-04-01","conditions":"Lower Limb Spasticity","enrollment":25},{"nctId":"NCT05142605","phase":"NA","title":"Evaluation of Grief Therapy Approaches for Bereaved Parents","status":"RECRUITING","sponsor":"University of Miami","startDate":"2022-03-31","conditions":"Grief, Bereavement, Cancer","enrollment":415}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":552,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Week 60","genericName":"Week 60","companyName":"University Hospital, Ghent","companyId":"university-hospital-ghent","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug targets the PD-1 receptor to inhibit cancer cell growth. Used for Non-small cell lung cancer, PD-L1 positive, Melanoma.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}